CCL2/CCR4参与子宫内膜异位症中肥大细胞介导的上皮间质转化
研究纳入18例卵巢子宫内膜异位症女性和13例无子宫内膜异位症女性,分离原代子宫内膜上皮细胞与HMC-1.1肥大细胞共培养,并建立野生型/c-kit突变型小鼠模型。结果发现浸润的活化肥大细胞数量与人子宫内膜异位病灶上皮间质转化正相关,肥大细胞通过MRGPRX2/CCL2/CCR4信号通路促进上皮细胞迁移和上皮间质转化,肥大细胞活化缺陷可抑制小鼠子宫内膜异位症发展。
要点
- 活化肥大细胞浸润数量与人子宫内膜异位病灶上皮间质转化正相关。
- 肥大细胞经MRGPRX2/CCL2/CCR4通路促进子宫内膜上皮细胞迁移和上皮间质转化。
- 小鼠模型中肥大细胞活化缺陷通过限制上皮间质转化抑制子宫内膜异位症发展。
核心结论
- 肥大细胞通过MRGPRX2/CCL2/CCR4/上皮间质转化信号参与子宫内膜异位症发病,靶向该通路可能成为潜在新治疗途径。
研究设计与样本
- 研究纳入18例卵巢子宫内膜异位症女性和13例无子宫内膜异位症女性。
- 分离纯化原代子宫内膜上皮细胞,与人肥大细胞系HMC-1.1共培养,体外探索肥大细胞对上皮间质转化的作用及机制。
- 体内建立野生型/c-kit突变型小鼠子宫内膜异位症模型,采用腹部同种异体子宫内膜移植法。
- 用免疫荧光染色测定人/小鼠子宫内膜组织中肥大细胞数量和位置,用定量逆转录聚合酶链反应、Western blot和免疫组化分析检测CCL2、CCR4及上皮间质转化相关分子表达。
主要发现
- 人子宫内膜异位病灶中浸润的活化肥大细胞数量与上皮间质转化正相关(CDH2,r=0.53,P=0.002;CDH1,r=-0.72,P<0.001)。
- 体外实验显示肥大细胞通过MRGPRX2/CCL2/CCR4信号通路促进子宫内膜上皮细胞迁移和上皮间质转化。
- 野生型/c-kit突变型小鼠子宫内膜异位症模型显示,肥大细胞活化缺陷通过限制上皮间质转化抑制子宫内膜异位症发展。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
RESEARCH QUESTION: Do mast cells play a role in the pathogenesis of endometriosis and, if so, what is the mechanism of action? DESIGN: The study included 18 women with ovarian endometriosis and 13 women without endometriosis. Primary endometrial epithelial cells (EPC) were isolated and purified, and co-cultured with human mast cell line HMC-1.1 to explore the role and mechanisms of mast cells on epithelial mesenchymal transition (EMT) in EPC in vitro. Then, wild/c-kitsh mouse model of endometriosis was established by abdominal allogeneic endometrial transplantation in vivo. The number and location of mast cells in human/mouse endometrial tissue were determined by immunofluorescence staining. The expression levels of molecules related to CCL2, CCR4 and EMT were measured by quantitative reverse transcription polymerase chain reaction, Western blot and immunohistochemical staining analysis, respectively. RESULTS: The number of infiltrated activated mast cells was positively correlated with EMT in human endometriotic lesions (CDH2, r = 0.53, P = 0.002; CDH1, r = -0.72, P < 0.001). Subsequently, mast cells promoted the migration and EMT of EPC through Mas-related G-protein-coupled receptor X2 (MRGPRX2)/C-C motif chemokine ligand 2 (CCL2)/C-C chemokine receptor 4 (CCR4) signalling pathway in vitro. Finally, wild/c-kitsh mouse model of endometriosis showed that deficiency of mast cell activation suppressed the development of endometriosis via the restriction of EMT. CONCLUSION: Mast cells are involved in the pathogenesis of endometriosis via MRGPRX2/CCL2/CCR4/EMT signals, thus providing a potential novel therapeutic approach for the treatment of endometriosis by targeting MRGPRX2/CCL2/CCR4 pathway.
引用
- Ding S, Mao X, Zhu L, et al. CCL2/CCR4 participates in mast cell-mediated epithelial mesenchymal transition in endometriosis. Reprod Biomed Online. 2025. PMID: 40472665. doi:10.1016/j.rbmo.2025.104796
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。